drugset / Trial / NCT00761228
Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury
Phase 2
Suspended
76 enrolled
NeuroHealing Pharmaceuticals Inc.
FDA Office of Orphan Products Development · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test the drug apomorphine in subjects who are in a Vegetative State or a Minimally Conscious State.
Timeline
- Start
- 2010-07
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Apomorphine | Unknown | 6 mg | Subcutaneous |